THE BEST SIDE OF HEMGENIX

Amount of suitable individuals: CDEC mentioned the uncertainty in the quantity of patients with moderately significant to intense hemophilia B in Canada eligible for etranacogene dezaparvovec. Clinical professionals consulted by CADTH indicated that some individuals who're labeled as owning moderate or average disease might have a severe bleeding p